Cargando…
Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study
BACKGROUND: The recent innovation activities of global top-tier pharmaceutical companies in accordance with global and regional health concerns were investigated in order to identify their innovations contributing to population health. METHODS: “Innovation activity” was defined as the number of drug...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481343/ https://www.ncbi.nlm.nih.gov/pubmed/32912258 http://dx.doi.org/10.1186/s12992-020-00610-2 |